Cases

Please use the links on the left to sort the items below according to category: investigations, new cases, featured cases and settlements. 

Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Home Properties, Inc.
June 24, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Home Properties, Inc. (“Home Properties” or the “Company”) (NYSE: HME), concerning the Company’s proposed acquisition by Lone Star Funds.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Martha Stewart Living Omnimedia
June 22, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Martha Stewart Living Omnimedia Inc. (“Martha Stewart Living” or the “Company”) (NYSE: MSO), concerning the Company’s proposed acquisition by Sequential Brands Group, Inc.
Finkelstein Thompson LLP Investigates Nvidia Corp.
June 22, 2015

Finkelstein Thompson LLP is investigating allegations that Nvidia Corp. overstated the processing capabilities of their GTX 970 computer graphics chip.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of KYTHERA Biopharmaceuticals, Inc.
June 18, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of KYTHERA Biopharmaceuticals, Inc. (“Kythera” or the “Company”) (NasdaqGS: KYTH), concerning the Company’s proposed acquisition by Allergan plc.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Dealertrack Technologies, Inc.
June 17, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Dealertrack Technologies, Inc. (“Dealertrack” or the “Company”) (NasdaqGS:TRAK), concerning the Company’s proposed acquisition by Cox Automotive, Inc.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Bio-Reference Laboratories, Inc.
June 09, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Bio-Reference Laboratories, Inc. (“BRLI” or the “Company”) (NASDAQ GS: BRLI), concerning the Company’s proposed acquisition by OPKO Health, Inc. (“OPKO”) (NYSE: OPK).
Finkelstein Thompson LLP Investigates FitBit, Inc.
June 05, 2015

Finkelstein Thompson LLP is investigating allegations that Fitbit’s activity monitors have manufacturing defects that cause skin irritation.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Altera Corporation
June 02, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Altera Corporation (“Altera” or the “Company”) (NASDAQ GS: ALTR), concerning the Company’s proposed acquisition by Intel Corporation (“Intel”) (NASDAQ GS: INTC).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Broadcom Corporation
May 29, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Broadcom Corporation (“Broadcom” or the “Company”) (NASDAQ GS: BRCM), concerning the Company’s proposed acquisition by Avago Technologies Limited (“Avago”) (NASDAQ GS: AVGO).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Rally Software Development Corp.
May 29, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Rally Software Development Corp. (NYSE: RALY), concerning the Company’s proposed acquisition by CA, Inc. (“CA”) (NASDAQ GS: CA).
Finkelstein Thompson LLP Investigates Etsy, Inc.
May 27, 2015

Finkelstein Thompson LLP is investigating securities claims on behalf of investors of Etsy, Inc. (NASDAQ GS: ETSY) resulting from a complaint alleging that Etsy may have issued materially misleading business information to the investing public.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Omnicare, Inc.
May 22, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Omnicare, Inc. (“Omnicare” or the “Company”) (NYSE: OCR), concerning the Company’s proposed acquisition by CVS Health Corporation.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of ANN INC.
May 19, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of ANN INC. (NYSE: ANN), concerning the Company’s proposed acquisition by Ascena Retail Group, Inc. (NASDAQ GS: ASNA).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of AOL Inc.
May 13, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of AOL Inc. (NYSE: AOL), concerning the Company’s proposed acquisition by Verizon Communications Inc. (NYSE: VZ).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Pall Corporation
May 13, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Pall Corporation (NYSE: PLL), concerning the Company’s proposed acquisition by Danaher Corporation (NYSE: DHR).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Quality Distribution, Inc.
May 12, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Quality Distribution, Inc. (Nasdaq: QLTY), concerning the Company’s proposed acquisition by Apax Partners (“Apax”).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Micrel, Incorporated
May 12, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Micrel, Incorporated (NASDAQ GS: MCRL), concerning the Company’s proposed acquisition by Microchip Technology Incorporated (NASDAQ GS: MCHP).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Synageva BioPharma, Inc.
May 12, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Synageva BioPharma, Inc. (Nasdaq: GEVA), concerning the Company’s proposed acquisition by Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Borderfree, Inc.
May 07, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Borderfree, Inc. (NASDAQ GS: BRDR), concerning the Company’s proposed acquisition by Pitney Bowes Inc. (NYSE: PBI).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Cyan, Inc.
May 05, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Cyan, Inc. (NYSE: CYNI), concerning the Company’s proposed acquisition by Ciena Corporation (NYSE: CIEN). 
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of iGate Corp.
April 29, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of iGate Corp. (Nasdaq: IGTE), concerning the Company’s proposed acquisition by Cap Gemini S.A. (PAR: CAP.PA).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Associated Estates Realty Corp.
April 27, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Associated Estates Realty Corporation (NYSE: AEC), concerning the Company’s proposed acquisition by a real estate fund managed by Brookfield Asset Management (“Brookfield”).
Finkelstein Thompson LLP Investigates Trader Joe's Co.
April 15, 2015

Finkelstein Thompson LLP is investigating allegations that grocery chain Trader Joe's violated state and federal law when the company restructured its workforce in March and April of 2014.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Excel Trust, Inc.
April 14, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Excel Trust, Inc. (“Excel” or the “Company”) (NYSE: EXL), concerning the Company’s proposed acquisition by Blackstone Property Partners L.P. (“Blackstone”).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Zep Inc.
April 09, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Zep Inc. (“Zep” or the “Company”) (NYSE: ZEP), concerning the Company’s proposed acquisition by New Mountain Capital, L.L.C. (“New Mountain”).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Informatica Corporation
April 08, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Informatica Corporation (NASDAQ GS: INFA), concerning the Company’s proposed acquisition by a company controlled by the Permira funds and Canada Pension Plan Investment Board (collectively, the “Consortium”).
Finkelstein Thompson LLP Investigates Honey Maid Graham Crackers
April 07, 2015

Finkelstein Thompson LLP is investigating reports that the Honey Maid Graham Crackers packaging contains a strong chemical odor.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Cellular Dynamics International
April 07, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Cellular Dynamics International, Inc. (NASDAQ GM: ICEL), concerning the Company’s proposed acquisition by FUJIFILM Holdings Corporation (“Fujifilm”).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Auspex Pharmaceuticals, Inc.
April 07, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Auspex Pharmaceuticals, Inc. (NASDAQ GM: ASPX), concerning the Company’s proposed acquisition by Teva Pharmaceuticals Industries Ltd. (NYSE: TEVA).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Norcraft Companies, Inc.
April 07, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Norcraft Companies, Inc. (NYSE: NCFT), concerning the Company’s proposed acquisition by Fortune Brands Home & Security, Inc. (NYSE: FBHS).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Hyperion Therapeutics, Inc.
April 07, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Hyperion Therapeutics, Inc. (NASDAQ GS: HPTX), concerning the Company’s proposed acquisition by Horizon Pharma plc (NASDAQ GS: HZNP).
Finkelstein Thompson LLP Investigates Mucinex™
March 25, 2015

Finkelstein Thompson LLP is investigating possible unfair trade practices on behalf of purchasers of Mucinex (extended-release guaifenesin) sold over-the-counter.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Vitesse Semiconductor Corp.
March 20, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Vitesse Semiconductor Corp. (NasdaqGM: VTSS), concerning the Company’s proposed acquisition by Microsemi Corp. (NasdaqGS: MSCC).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Life Time Fitness, Inc.
March 17, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Life Time Fitness, Inc. (NYSE: LTM), concerning the Company’s proposed acquisition by Leonard Green & Partners and TPG.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Integrated Silicon Solution, Inc.
March 16, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Integrated Silicon Solution, Inc. (NASDAQ GS: ISSI), concerning the Company’s proposed acquisition by Summitview Capital.
Finkelstein Thompson LLP Investigates Kohl’s Credit Card
March 11, 2015

Finkelstein Thompson LLP is investigating Kohl’s Corporation Inc. over alleged deceptive tactics in credit card charges.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of The Macerich Company
March 10, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of The Macerich Company (NYSE: MAC), concerning the Company’s proposed acquisition by Simon Property Group, Inc. (NYSE: SPG). 
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Pharmacyclics, Inc.
March 09, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Pharmacyclics, Inc. (NASDAQ GS: PCYC), concerning the Company’s proposed acquisition by AbbVie Inc. (NYSE: ABBV).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Aruba Networks
March 04, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Aruba Networks (NASDAQ: ARUN), concerning the Company’s proposed acquisition by Hewlett-Packard (NYSE: HPQ).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Emulex Corporation
February 27, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Emulex Corporation (NYSE: ELX), concerning the Company’s proposed acquisition by Avago Technologies Limited (NASDAQ GS: AVGO).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Polypore International, Inc.
February 24, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Polypore International, Inc. (NYSE: PPO), concerning the Company’s proposed acquisition by Asahi Kasei Corporation (“Asahi Kasei”).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Salix Pharmaceuticals, Ltd.
February 24, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Salix Pharmaceuticals, Ltd. (NASDAQ GS: SLXP), concerning the Company’s proposed acquisition by Valeant Pharmaceuticals International, Inc. (NYSE: VRX).
Finkelstein Thompson LLP Investigates Lenovo
February 20, 2015

Finkelstein Thompson LLP is investigating allegations that the computer manufacturing company, Lenovo, has been installing adware onto new consumer PCs since at least mid-2014. 

Finkelstein Thompson LLP Investigates Hyundai Motor America
February 19, 2015

Finkelstein Thompson LLP is investigating allegations that Hyundai has marketed it’s Blue Link Telematics System as a standard feature then notifying owners years later after the purchase of the vehicle that the feature would be permanently disabled unless a fee is paid to renew the subscription.
Finkelstein Thompson LLP Investigates Nestlé Purina's Beneful Dog Food
February 19, 2015

Finkelstein Thompson LLP is investigating allegations that Nestlé Purina's Beneful Dog Food has killed or extremely sickened thousands of dogs.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Orbitz Worldwide, Inc.
February 13, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Orbitz Worldwide, Inc. (NYSE: OWW), concerning the Company's proposed acquisition by Expedia, Inc. (NASDAQ GS: EXPE).
Finkelstein Thompson LLP Investigates Herbal Supplements
February 10, 2015

Finkelstein Thompson LLP is investigating allegations that several brands of Herbal Supplements may not contain the active supplement advertised on the bottle.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Hospira Inc.
February 06, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Hospira Inc. (NYSE: HSP), concerning the Company's proposed acquisition by Pfizer Inc. (NYSE: PFE).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of E2open, Inc.
February 06, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of E2open, Inc. (NASDAQ: EOPN), concerning the Company's proposed acquisition by Insight Venture Partners.

Finkelstein Thompson LLP Investigates Recent Anthem Inc. Data Breach
February 05, 2015

Attorney Advertising. Finkelstein Thompson LLP is investigating the recent Anthem Inc. data breach that has potentially exposed highly sensitive personal information of as many as 80 million health insurance customers.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Office Depot Inc.
February 04, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Office Depot Inc. (NASDAQ: ODP), concerning the Company's proposed acquisition by Staples, Inc. (NASDAQ: SPLS)
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Advent Software Inc.
February 04, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Advent Software Inc. (NASDAQ: ADVS), concerning the Company's proposed acquisition by SS&C Technologies Holdings, Inc. (NASDAQ: SSNC).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Silicon Image Inc.
January 28, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Silicon Image Inc. (NASDAQ: SIMG), concerning the Company's proposed acquisition by Lattice Semiconductor.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Lakes Entertainment, Inc.
January 28, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Lakes Entertainment, Inc. (Nasdaq: LACO), concerning the Company’s proposed acquisition by Golden Gaming, LLC.
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of City National Corp.
January 23, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of City National Corp. (NYSE: CYN), concerning the Company’s proposed acquisition by Royal Bank of Canada (TSX: RY).
Finkelstein Thompson LLP Investigates Recent Data Breach at Kmart
January 21, 2015

Finkelstein Thompson LLP is investigating a recent data breach that occurred at Kmart. On October 10, 2014, Kmart President and Chief Member Officer, Alasdair James, informed Kmart customers that the store payment data system had been breached.
Finkelstein Thompson LLP Investigates Bayer’s Flintstones Healthy Brain Support Supplement
January 21, 2015

Finkelstein Thompson LLP is investigating allegations that Bayer’s Flintstones Gummies has falsely advertised the Flintstones Healthy Brain Support supplement as able to “Support Healthy Brain Function.” 
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of NPS Pharmaceuticals Inc.
January 21, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of NPS Pharmaceuticals Inc. (NPSP), concerning the Company’s proposed acquisition by Shire PLC (SHPGF).
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of MWI Veterinary Supply, Inc.
January 21, 2015

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of MWI Veterinary Supply, Inc. (NASDAQ: MWIV), concerning the Company’s proposed acquisition by AmerisourceBergen Corporation (NYSE: ABC).
Finkelstein Thompson LLP Investigates Chia Crisps
December 23, 2014

Finkelstein Thompson LLP is investigating recent allegations that Chia Crisps snacks are primarily made of black beans and not chia seeds.

Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of PetSmart, Inc.
December 15, 2014

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of PetSmart, Inc. (PETM), concerning the Company’s proposed acquisition by BC Partners.

Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Cubist Pharmaceuticals, Inc.
December 15, 2014

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Cubist Pharmaceuticals, Inc. (NASDAQ: CBST), concerning the Company's proposed acquisition by Merck & Co. (NYSE: MRK).

Finkelstein Thompson LLP Investigates Lands' End 'Made in U.S.A' Label
December 09, 2014

Finkelstein Thompson LLP is investigating allegations that Lands' End, an online and catalogue-based clothing company, has falsely claimed their apparel is made domestically.

Finkelstein Thompson LLP Investigates Mercedes Benz Gasoline Leaks
December 02, 2014

Finkelstein Thompson LLP is investigating allegations that certain Mercedes-Benz vehicles have defective gasoline tanks that can lead to gasoline vapors entering the passenger cabin and/or gasoline soaking some of the car seats.
Gateway Settlement
November 19, 2014

On November 7, 2014, the United States District Court for the Central District of California preliminarily approved a proposed settlement in the case titled, Lima v. Gateway, Inc.
The Securities and Exchange Commission Is Probing Brokerages Over Handling of Retail Orders
October 28, 2014

The Securities and Exchange Commission (“SEC”) is probing brokerages over the handling of retail orders.

Finkelstein Thompson LLP Investigates Alleged Disclosure of Customers' Personal Information by AMC
October 28, 2014

Finkelstein Thompson LLP investigating allegations that AMC Networking Entertainment, LLC and  AMC Networks, Inc. are improperly disclosing customers' personal information to Facebook.

Finkelstein Thompson LLP Investigating Allegations That Several Companies Fixed Capacitor Prices
September 23, 2014

Finkelstein Thompson LLP is investigating allegations that a number of companies engaged in the unlawful price fixing of capacitor prices. These companies are accused of conspiring to fix the prices of aluminum, tantalum, film and ceramic capacitors for nearly a decade.

Finkelstein Thompson LLP Investigates Canon Pixma Printer Failures
September 16, 2014

Based on a recently filed complaint, Finkelstein Thompson LLP is investigating allegations that certain Canon Pixma brand printers are rendered totally useless after displaying the error message “U052: Wrong Printhead Error.”

Finkelstein Thompson LLP Investigating Retailers for Alleged False Advertising of Apparel Prices
September 09, 2014

Finkelstein Thompson LLP is investigating retailers Neiman Marcus, Saks Fifth Avenue, The Gap, and Banana Republic for deceptively marketing items at outlet stores to suggest that discounts received by customers are greater than they actually are.   

Finkelstein Thompson LLP Investigating Oil Consumption Defect in Certain Subaru Vehicles
September 02, 2014

Finkelstein Thompson LLP is investigating allegations that certain Subaru vehicles consume or burn off excessive amounts of oil that burden customers with expensive repair bills.

Finkelstein Thompson LLP Investigating Allegedly Defective WEN Hair Products That Cause Hair Loss
August 21, 2014

Finkelstein Thompson LLP is investigating Guthy-Renker LLC (“Guthy-Renker”) for manufacturing and marketing allegedly defective WEN Cleansing Conditioners that cause significant hair loss.

Capitol Park Towers Apartments Settlement Notice
June 30, 2014

The DC Superior Court has preliminarily approved a settlement in the class action lawsuit Chaney, et al. v. Capitol Park Associates, et al. 

Finkelstein Thompson LLP Investigates Currency Conversion Fees Charged By Hertz Corporation
April 01, 2014

Consumers who traveled abroad and rented a car from Hertz Corporation (Hertz) may have been overcharged by the company due to its currency conversion fee.

Finkelstein Thompson LLP Investigates Second Generation Nest Learning Thermostats
April 01, 2014

Consumers who purchased the Second Generation Nest Learning Thermostat may be experiencing inaccurate thermostat readings due to the thermostat overheating.

Finkelstein Thompson LLP Comments on SEC Proposed Crowdfunding Rule
February 05, 2014

The U.S. Securities and Exchange Commission recently proposed regulations to implement Title III of the Jumpstart Our Business Startups (“JOBS”) Act and Section 4(a)(6) to the Securities Act of 1933 in which Congress created an exemption to securities registration requirements that would equity-based crowdfunding. As a firm with more than four decades of experience in securities law, Finkelstein Thompson LLP is actively engaged in the development of this new industry and submitted comments in response to the SEC’s proposed rules.

Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Beam, Inc.
January 13, 2014

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Beam, Inc., concerning the Company’s proposed acquisition by Suntory Holdings Limited.

Debt Collection Companies May Be Violating the TCPA in Order to Collect Unpaid Medical Bills
January 09, 2014

There have been a recent number of complaints against medical debt collection companies for telephone calls made to patients for billing purposes.

Ninth Circuit Reinstates Claims Against Sony for Removal of the Other Operating System
January 08, 2014

PlayStation®3 (“PS3”) owners won a significant appeal that will allow consumers to pursue their claims that Sony caused damages by disabling the heavily advertised ability to run another operating system and use the PS3 as a computer.

Finkelstein Thompson Defeats NASDAQ’S Motion to Dismiss Case Over Botched Facebook IPO
December 18, 2013

Shareholders who participated in Facebook’s (NASDAQ: FB) botched IPO won a victory on December 11, 2013, when Judge Sweet of the Southern District of New York rejected NASDAQ’s (NASDAQ: NDAQ) motion to dismiss a class action lawsuit alleging NASDAQ negligently failed to properly test and design its systems.

Potential Relief for California Residents Stuck Paying for Reoccurring Charges or Automatic Renewals
December 16, 2013

Frequently, consumers find themselves paying for reoccurring charges that they have no recollection agreeing to. Finkelstein Thompson LLP is investigating the rights and potential remedies of California residents paying reoccurring charges.

Dry Max Pampers Important Notice
December 09, 2013

On December 5, 2013, the Honorable Timothy S. Black issued an important notice in the case titled In re Dry Max Pampers Litigation, which is pending in the U.S. District Court for the Southern District of Ohio. The litigation relates to the marketing and sales of Dry Max Pampers.

Finkelstein Thompson LLP Investigates Biodegradable Plastics in California
November 26, 2013

Finkelstein Thompson LLP is investigating the potential deceptive marketing and labeling of plastic products in California as biodegradable.

Naked Juice Class Settlement
September 16, 2013

On August 7, 2013, the Honorable John A. Kronstadt approved of a $9 million cash settlement in the case titled Pappas v. Naked Juice Co. of Glendora, Inc.

Finkelstein Thompson LLP was appointed co-lead class counsel. Please visit the Naked Juice settlement website for more information.

Finkelstein Thompson LLP Announces Investigation of TMS International Corp. Buyout
August 26, 2013

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of TMS International Corp. (“TMS” or “the Company”), concerning the proposed acquisition by The Pritzker Organization, LLC (“Pritzker”).

Finkelstein Thompson LLP Announces Investigation of Inteliquent, Inc.
August 08, 2013

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Inteliquent, Inc. (“Inteliquent” or “the Company”) related to the Company’s announcement that it would delay its second-quarter earnings call as a result of an ongoing investigation by the Board of Directors’ audit committee into a charge taken last year and its financial forecasting.

Finkelstein Thompson LLP Investigates Allegations of Lead in Clif Bars
August 06, 2013

Finkelstein Thompson LLP is investigating whether consumers who purchased certain types of Clif bars may be entitled to compensation.

Finkelstein Thompson LLP Announces Investigation of Trius Therapeutics, Inc. Buyout
July 31, 2013

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Trius Therapeutics, Inc., concerning the proposed acquisition by Cubist Pharmaceuticals, Inc.

Finkelstein Thompson LLP Announces Investigation of Optimer Pharmaceuticals, Inc. Buyout
July 31, 2013

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Optimer Pharmaceuticals, Inc., concerning the proposed acquisition by Cubist Pharmaceuticals, Inc.

Finkelstein Thompson LLP Announces Investigation of Saks, Inc. Buyout
July 29, 2013

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Saks, Inc., concerning the proposed acquisition by Hudson’s Bay Company.

Finkelstein Thompson Investigates Allegations of Price Fixing of Korean Noodles
July 26, 2013

Finkelstein Thompson LLP is investigating whether consumers that purchased Korean noodles may be entitled to compensation.

Finkelstein Thompson LLP Investigates Essentia Natural Memory Foam Mattresses
July 26, 2013

Finkelstein Thompson LLP is investigating whether consumers that purchased Essentia mattresses may be entitled to compensation.

Finkelstein Thompson LLP Announces Investigation of CapitalSource, Inc. Buyout
July 23, 2013

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of CapitalSource, Inc., concerning the proposed acquisition by PacWest Bancorp.

Finkelstein Thompson LLP is Investigating Starion Energy, Inc.
July 18, 2013

Finkelstein Thompson LLP is investigating allegations that Starion Energy, Inc. (“Starion”) and other alternative energy suppliers may have engaged in unfair and deceptive practices in marketing electricity services to District of Columbia residents.

Finkelstein Thompson LLP Announces Investigation of SHFL entertainment, Inc. Buyout
July 16, 2013

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of SHFL entertainment, Inc., concerning the proposed acquisition by Bally Technologies, Inc.

Class Action Settlement with Allergan, Inc.
February 21, 2013

Finkelstein Thompson LLP is pleased to announce that the Honorable Philip Gutierrez of the United States District Court, Central District of California, granted preliminary approval of a $7,750,000 million dollar settlement with Allergan, Inc. in the case titled, Dr. Julio Garcia v. Allergan, Inc., Case No. CV 11-9811-PSG (Ex). The settlement resolves a nationwide class action suit against Allergan based on allegations that the company promoted the use of one vial of BOTOX® Cosmetic on more than one patient. The lawsuit did not allege that BOTOX® Cosmetic is unsafe or ineffective. Allergan denies the allegations.

GranuFlo and Naturalyte May Cause Heart Problems
November 14, 2012

If you took GranuFlo and Naturalyte and underwent hemodialysis and suffered any serious adverse health effects, please call (877) 800-1450 to speak to Finkelstein Thompson LLP attorneys who are available to analyze your situation at no cost or obligation to you. If you do not know if Granuflo was used for your hemodialysis treatment, Finkelstein Thompson LLP can even help you learn that information.

GranuFlo and Naturalyte are used to treat acute and chronic renal (kidney) failure during hemodialysis. The Food and Drug Administration ("FDA") recalled the drugs after they were linked to serious adverse health effects.  These drugs were part of a Class I recall which are the most serious type of recall issued by the FDA.  Class I recalls involve situations in which there is a reasonable probability that use of the recalled products will cause serious adverse health consequences or death. Indeed, as a result of the formulation of Naturalyte and GranuFlo, it is believed patients were at a higher risk of heart and cardiovascular injuries, including cardiac arrest, heart attacks, congestive heart failure, and death.

Medtronic InFUSE® Bone Graft Can Cause Harm
November 12, 2012

Finkelstein Thompson LLP is investigating allegations that Medtronic, Inc. illegally promoted and attempted to conceal the adverse events associated with InFUSE® Bone Graft ("InFUSE"), Medtronic, Inc.'s bio-engineered bone graft device used for spinal surgery. It is alleged that Medtronic, Inc. illegally promoted the off-label use of InFUSE for posterior lumbar surgery, when InFUSE is FDA-approved for anterior or abdominal lumbar surgery. It is also alleged that Medtronic, Inc. intentionally minimized or downplayed the risks of serious side effects related to the use of InFUSE, including ectopic or uncontrolled bone growth, inflammatory reactions, back and leg pain events, urinary retention, retrograde ejaculation, and implant displacement.

Finkelstein Thompson LLP Investigates The Flushmate III Pressure-Assisted Flushing System
August 20, 2012

Recently the U.S. Consumer Product Safety Commission ("CPSC") announced a voluntary recall of the Flushmate III Pressure-Assisted Flushing System ("Flushmate III"). The Flushmate III presents a hazard of bursting at or near the vessel weld seam with a force strong enough to shatter the tank. The CPSC has already received 304 reports of the product bursting, resulting in property damage  and 14 impact or laceration injuries.

Merix
December 15, 2011

On November 16, 2011, the Circuit Court of Oregon, Multnomah County, entered a judgment and opinion granting final approval of a settlement providing $1.5 million to former shareholders of Merix Corporation. Finkelstein Thompson LLP ("FT") was appointed Co-Lead Counsel in this securities class action alleging that the Merix Board of Directors breached their fiduciary duties to Merix shareholders in connection with the approval of a merger with Viasystems Group, Inc. in October 2009. The certified class consists of all persons who held any Merix common stock continuously from October 6, 2009 through and including February 16, 2010.